Nanoparticles for fluorescence-guided breast cancer surgery: advances in <i>in vivo</i> preclinical research
preclinical breast cancer models, and reported clearance pathways and safety profiles. Despite the remaining translational challenges, significant progress is being made in the preclinical development of innovative nanoparticle imaging agents for fluorescence-guided surgery of breast cancer, which demonstrates their potential application for clinical studies.
Authors
- N. Zahraie (ORCID: https://orcid.org/0009-0008-8689-8179)
- Alexandru Chivu (ORCID: https://orcid.org/0000-0002-8573-9159)
- Elnaz Yaghini (ORCID: https://orcid.org/0000-0001-5348-4625)
- A. J. MacRobert
- Hirak Patra
Institutions
- University College London (GB)
Publication Details
- Journal
- Nanomedicine
- Published
- 2026-08-18
- DOI
- https://doi.org/10.1080/17435889.2026.2715009
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00